NO144670C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-substituerte-3-pyrrolidinyl)-1-nafthalen- og 4-kinolincarboxamider - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-substituerte-3-pyrrolidinyl)-1-nafthalen- og 4-kinolincarboxamider

Info

Publication number
NO144670C
NO144670C NO754376A NO754376A NO144670C NO 144670 C NO144670 C NO 144670C NO 754376 A NO754376 A NO 754376A NO 754376 A NO754376 A NO 754376A NO 144670 C NO144670 C NO 144670C
Authority
NO
Norway
Prior art keywords
pyrrolidinyl
naphthalene
substituted
preparation
therapeutic active
Prior art date
Application number
NO754376A
Other languages
English (en)
Norwegian (no)
Other versions
NO754376L (fr
NO144670B (no
Inventor
Albert Duncan Cale Jr
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of NO754376L publication Critical patent/NO754376L/no
Publication of NO144670B publication Critical patent/NO144670B/no
Publication of NO144670C publication Critical patent/NO144670C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
NO754376A 1974-12-26 1975-12-23 Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-substituerte-3-pyrrolidinyl)-1-nafthalen- og 4-kinolincarboxamider NO144670C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/536,514 US4002757A (en) 1974-12-26 1974-12-26 N-(1-substituted-3-pyrrolidinyl)-4-quinolinecarboxamides

Publications (3)

Publication Number Publication Date
NO754376L NO754376L (fr) 1976-06-29
NO144670B NO144670B (no) 1981-07-06
NO144670C true NO144670C (no) 1981-10-14

Family

ID=24138812

Family Applications (1)

Application Number Title Priority Date Filing Date
NO754376A NO144670C (no) 1974-12-26 1975-12-23 Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-substituerte-3-pyrrolidinyl)-1-nafthalen- og 4-kinolincarboxamider

Country Status (18)

Country Link
US (3) US4002757A (fr)
JP (2) JPS5191254A (fr)
AU (1) AU499075B2 (fr)
BE (1) BE836975A (fr)
CA (1) CA1071636A (fr)
CH (1) CH611603A5 (fr)
DE (1) DE2558348A1 (fr)
DK (1) DK138536B (fr)
ES (1) ES443845A1 (fr)
FI (1) FI61480C (fr)
FR (1) FR2295744A1 (fr)
GB (1) GB1537848A (fr)
IE (1) IE43819B1 (fr)
NL (1) NL7515084A (fr)
NO (1) NO144670C (fr)
PH (1) PH13883A (fr)
SE (1) SE408417B (fr)
ZA (1) ZA757972B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4279822A (en) * 1972-04-03 1981-07-21 A. H. Robins Company, Inc. N-(1-Substituted-3-pyrrolidinyl)benzamides
US4002757A (en) * 1974-12-26 1977-01-11 A. H. Robins Company, Incorporated N-(1-substituted-3-pyrrolidinyl)-4-quinolinecarboxamides
US4143150A (en) * 1977-08-19 1979-03-06 A. H. Robins Company, Inc. Derivatives of oxanilic acid
US4703056A (en) * 1983-01-21 1987-10-27 Alkaloida Vegyeszeti Gyar New alkyl diamine derivatives
US5210329A (en) * 1992-02-18 1993-05-11 General Electric Company Process for preparing bisphenol-A
US6673829B2 (en) 2001-09-14 2004-01-06 Novo Nordisk A/S Aminoazetidine,-pyrrolidine and -piperidine derivatives
DE60237528D1 (de) 2001-09-14 2010-10-14 High Point Pharmaceuticals Llc Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative
ES2305776T3 (es) 2003-06-17 2008-11-01 Pfizer Inc. Derivados de n-pirrolidin-3-il-amida como inhibidores de la re-captacion de serotonina y noradrenalina.
US7348434B2 (en) * 2003-08-08 2008-03-25 Antony Bigot 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
WO2006064336A2 (fr) * 2004-12-14 2006-06-22 Pfizer Limited Nouveaux composes
CA2590226A1 (fr) * 2004-12-14 2006-06-22 Pfizer Limited Derives de n-pyrrolidin-3yl-amide en tant qu'inhibiteurs de recaptage de la serotonine et de la noradrenaline
EP1828122A2 (fr) * 2004-12-16 2007-09-05 Pfizer Limited Dérivés de n-pyrrolidin-3-yl-amide comme inhibiteurs de recaptage de la sérotonine et noradrénaline
EP2481735A1 (fr) * 2007-05-09 2012-08-01 Pfizer Inc. Dérivés hétérocycliques substitués et leur utilisation pharmaceutique et compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1825623A (en) * 1931-09-29 Oonhohachzn
DE67123C (de) * L. THOMAS in Montegnee-les-Siege, Belgien Handdrehbohrmaschine für Gruben und Steinbrüche
US3133061A (en) * 1962-11-13 1964-05-12 Sterling Drug Inc Piperidine carboxamides and derivatives thereof
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
US3577440A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-amido-pyrrolidines
GB1364231A (en) * 1968-12-23 1974-08-21 Robins Co Inc A H N-/1-substituted-3-pyrrolidinyl/benzamides and thiobenzamides
US3829434A (en) * 1972-11-10 1974-08-13 Pfizer Piperidinesulfonylurea derivatives
US4002757A (en) * 1974-12-26 1977-01-11 A. H. Robins Company, Incorporated N-(1-substituted-3-pyrrolidinyl)-4-quinolinecarboxamides

Also Published As

Publication number Publication date
ZA757972B (en) 1976-12-29
CH611603A5 (fr) 1979-06-15
DK589075A (fr) 1976-06-27
AU499075B2 (en) 1979-04-05
CA1071636A (fr) 1980-02-12
DK138536C (fr) 1979-03-05
FI753606A (fr) 1976-06-27
FR2295744A1 (fr) 1976-07-23
IE43819B1 (en) 1981-06-03
GB1537848A (en) 1979-01-04
JPS619314B2 (fr) 1986-03-22
NO754376L (fr) 1976-06-29
FI61480C (fi) 1982-08-10
NO144670B (no) 1981-07-06
DE2558348A1 (de) 1976-07-08
ES443845A1 (es) 1977-04-16
FI61480B (fi) 1982-04-30
JPS60248684A (ja) 1985-12-09
JPS5191254A (en) 1976-08-10
AU8755075A (en) 1977-06-23
BE836975A (fr) 1976-04-16
US4073796A (en) 1978-02-14
SE7514374L (sv) 1976-06-28
DK138536B (da) 1978-09-25
US4002757A (en) 1977-01-11
PH13883A (en) 1980-10-27
NL7515084A (nl) 1976-06-29
IE43819L (en) 1976-06-26
JPS611426B2 (fr) 1986-01-17
FR2295744B1 (fr) 1978-07-28
SE408417B (sv) 1979-06-11
US4087428A (en) 1978-05-02

Similar Documents

Publication Publication Date Title
NO144262C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme n-substituerte benzamidderivater
NO151320C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv pyrrolidylmetyl-2-metoksy-4-amino-5-isopropyl-sulfonylbenzamider
SE432420B (sv) Forfarande for framstellning av terapeutiskt verksamma hydroxamsyror
NO144670C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-substituerte-3-pyrrolidinyl)-1-nafthalen- og 4-kinolincarboxamider
SE411753B (sv) Forfarande for framstellning av terapeutiskt aktiva nya derivat av n-(1-bensylpyrrolidinyl-2-alkyl)-bensamid
NO146865C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 16-dehydro-androstanderivater
NO144926C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-benzazolylalkyl-4-substituerte piperidiner
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO151319C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-mono-fluormetyl-beta-alanin- og beta-difluormetyl-beta-alanin-forbindelser
NO144108C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider
NO143381C (no) Analogifremgangsmaate ved fremstilling av farmakologisk aktive guanidin- og isotioureaderivater
NO140824C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7alfa-hydroxy-oestratriener
NO151410C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(2-klorethyl)-n-nitrosourea-forbindelser
SE431204B (sv) Forfarande for framstellning av n?722-naftalensulfonyl-l-argininestrar och -amider eller farmaceutiskt accepterbara syraadditionssalter derav
NO152128C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-amino-3-benzoylfenylacetamider
NO147485C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater
NO143317C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tiazindioksyder
NO137894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive amidoksimer
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater
NO145383C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler.
NO146672C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cinnolinderivater
NO139733C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av metylamin
SE414029B (sv) Forfarande for framstellning av terapeutiskt aktiva fentiazinderivat
NO143502C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrano-kinolinkarboksylsyrer
NO144632C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive dianhydroheksitid-acyl-derivater